Everolimus and pasireotide for advanced and metastatic hepatocellular carcinoma
- Sanoff, Hanna K.
- Kim, Richard
- Ivanova, Anastasia
- Alistar, Angela
- McRee, Autumn J.
- O’Neil, Bert H.
Publication date
January 2015
DOIAbstract
Few treatment options are available for patients with advanced or metastatic hepatocellular carcinoma (HCC). Based on preclinical and early clinical efficacy signals and lack of overlapping toxicity, we undertook this multicenter phase II trial to estimate efficacy and safety of everolimus and pasireotide in advanced HCC
Add to ORKG